Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Patient-derived Spheroids
50%
SUMOylation
50%
SUMO2
50%
Alpha-synuclein (α-syn)
50%
Patient Management
50%
Oncology
50%
Therapeutic Response
50%
Functional Profiling
50%
Pancreatic Cancer Organoids
50%
Metastatic Colorectal Cancer (mCRC)
50%
Minimal Residual Disease
50%
Autophagy
50%
IRCCS
25%
Advanced Modeling
25%
Genomic Sequencing
20%
Clinical Outcomes
20%
Genetic Features
20%
Standard of Care
20%
Treatment Response
17%
Autophagy Pathway
16%
Hematological Malignancies
14%
Solid Tumors
14%
Inhibitory KIR
12%
Clinical Applicability
10%
Clinical Tumor
10%
Anti-VEGFR
10%
Anti-EGFR Drugs
10%
Cancer Cell Lines
10%
Therapeutic Challenges
10%
Calcein
10%
Predictive Value
10%
Drug Response Prediction
10%
Tumor Genetics
10%
Anticancer Drugs
10%
3D Model
10%
Cell Viability
10%
Drug Screening
10%
Clinical Treatment
10%
Drug Resistance
10%
ERBB2
10%
Small Molecules
10%
Drug Response
10%
Patient Tumor
10%
Tumor
10%
Histopathological Features
10%
Autophagy-related Diseases
8%
Therapeutic Leads
8%
SPR Analysis
8%
Nuclear Translocation
8%
Autophagy-related Genes
8%
Parkinson's Disease
8%
Neurodegenerative Diseases
8%
Mode of Action
8%
Potential Therapeutics
8%
Cellular Survival
8%
New Therapeutic Modality
8%
Acral
8%
Dissociation Constant
8%
Cellular Homeostasis
8%
DeSUMOylation
8%
ULK1
8%
Chemical Probes
8%
Forkhead Box O3 (FOXO3)
8%
Autophagy Regulators
8%
Thermal Shift Assay
8%
Modulatory
8%
Parkinson's Disease Model
8%
Family Genes
8%
Drug Treatment Response
8%
Maintenance Optimization
7%
Risk-informed
7%
Serial Monitoring
7%
Digital PCR (dPCR)
7%
Binary Indicators
7%
Assay Standardization
7%
Longitudinal Biomarker
7%
Cell-derived
7%
Solid Malignancies
7%
Optimization Strategy
7%
Detection Method
7%
AI-driven
7%
Sensitive Detection
7%
Clinical Application
7%
Treatment Adaptation
7%
Human Intestinal Tract
7%
Tumor-derived
7%
Multiparameter Flow Cytometry
7%
Disease Management
7%
Next-generation Sequencing
7%
Conventional Diagnostic Methods
7%
Multi-omics
7%
Quantitative PCR
7%
Tumor-specific
7%
Cancer Types
7%
Residual Disease
7%
Surveillance Strategy
7%
Circulating Tumor DNA (ctDNA)
7%
Analytical Framework
7%
Cancer Management
7%
Detection Technology
7%
Medicine and Dentistry
Malignant Neoplasm
56%
Treatment Response
56%
Organoid
50%
Disease Model
50%
Melanoma
50%
Oncology
50%
Minimal Residual Disease
50%
Patient Care
50%
Metastatic Colorectal Cancer
50%
Tumor Spheroid
50%
Neoplasm
36%
Tumor
30%
Genetics
30%
Drug Response
20%
Genome Sequencing
20%
Precision Oncology
16%
Cancer
13%
Biological Marker
12%
Solid Malignant Neoplasm
12%
Diseases
10%
Epidermal Growth Factor Receptor
10%
Personalized Medicine
10%
Drug Resistance
10%
Cancer Therapy
10%
Drug Screening
10%
Translational Oncology
10%
Clinical Decision Making
10%
Cancer Cell
10%
Human Tissue
10%
Tumor Cell
10%
Adenosine Triphosphate
10%
Anticarcinogen
10%
Cell Viability
10%
Ex Vivo
10%
Acute Myeloid Leukemia
7%
Therapeutic Modality
7%
Cell Oncogene
7%
Mortality Rate
7%
Proto Oncogene
7%
Mastocytosis
7%
Pathogenesis
7%
Cell Growth
7%
Gastrointestinal Stromal Tumor
7%
Cell Proliferation
7%
Therapeutic Target
7%
Cell Survival
7%
Artificial Intelligence
6%
Multi-Omics
6%
Specific Tumor
6%
Next Generation Sequencing
6%
Sensitive Detection
6%
Molecular Profiling
6%
Circulating Tumor DNA
6%
Real-Time Polymerase Chain Reaction
6%
Nucleic Acid
6%
Hematologic Malignancy
6%
Disease Management
6%
Polymerase Chain Reaction
6%
Diagnosis
6%
Flow Cytometry
6%
Cancer Types
6%
Pharmacology, Toxicology and Pharmaceutical Science
Patient-Derived Organoid
100%
Epidermal Growth Factor Receptor
66%
Protein Tyrosine Kinase Inhibitor
50%
Diseases
50%
Structure Activity Relationship
50%
Metastatic Colorectal Cancer
50%
Lung Cancer
50%
Pancreas Cancer
50%
Malignant Pleura Effusion
50%
Melanoma
50%
Malignant Neoplasm
46%
Drug Resistance
35%
Neoplasm
33%
Drug Screening
29%
Pancreas Adenocarcinoma
18%
Adenosine Triphosphate
16%
Anticarcinogen
16%
Calcein
16%
Cell Viability
16%
Tumor Microenvironment
12%
Chlordiazepoxide
10%
Pharmacotherapy
10%
Non Small Cell Lung Cancer
10%
Acute Myeloid Leukemia
7%
Pathogenesis
7%
Mastocytosis
7%
Cellular Processes
7%
Mortality Rate
7%
Gastrointestinal Stromal Tumor
7%
Therapeutic Effect
6%
Repurposing
6%
Biological Marker
6%
Tamsulosin
6%
Primary Tumor
6%
Drug Discovery
6%